6461 Share Price Performance
NT$0
-30.63 (-100.00%)
Price NT$0
Share Pricen/a
Intech Biopharm Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
6461 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Intech Biopharm Corporation Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -4.37
- -382.42%
- -992.81%
- 148.4%
About 6461
- Founded
- 2010
- Employees
- 96
- CEO
- WebsiteView website
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. The company offers combinations, formulations, and generic drugs for the treatment of respiratory diseases using technology platforms, such as inhaled low ethanol formulation, a metered dose inhaler platform for treating asthma and COPD, as well as dry powder inhaler that comprises blisters and capsules. Its products include SYN006, SYN010, SYN007, Synflutide, Duasma,Synvent, and SYN011. The company was founded in 2010 and is headquartered in Taipei, Taiwan.
